Home
/
VOLITIONRX LTD
/
Financials
/
Quarterly
VOLITIONRX LTD — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that VOLITIONRX LTD filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$627.3K
Nov 13, 2025
Q2
2025
Jun 30, 2025
$406.7K
Aug 14, 2025
Q1
2025
Mar 31, 2025
$246.4K
May 15, 2025
Q3
2025
Sep 30, 2024
$474.5K
Nov 13, 2025
Q2
2025
Jun 30, 2024
$395.8K
Aug 14, 2025
Q1
2025
Mar 31, 2024
$171.5K
May 15, 2025
Q3
2024
Sep 30, 2023
$165.2K
Nov 14, 2024
Q2
2024
Jun 30, 2023
$216.3K
Aug 14, 2024
Q1
2024
Mar 31, 2023
$149.8K
May 13, 2024
Q3
2023
Sep 30, 2022
$32.7K
Nov 14, 2023
Q2
2023
Jun 30, 2022
$39.8K
Aug 14, 2023
Q1
2023
Mar 31, 2022
$114.2K
May 10, 2023
Q3
2022
Sep 30, 2021
$25.5K
Nov 14, 2022
Q2
2022
Jun 30, 2021
$24.8K
Aug 10, 2022
Q1
2022
Mar 31, 2021
$25.5K
May 11, 2022
Q3
2021
Sep 30, 2020
$575
Nov 10, 2021
Q2
2021
Jun 30, 2020
$5.2K
Aug 11, 2021
Q1
2021
Mar 31, 2020
$544
May 11, 2021
Q3
2020
Sep 30, 2019
$17.1K
Nov 12, 2020
Q2
2020
Jun 30, 2019
$0
Aug 13, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($5.38M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($6.28M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($5.42M)
May 15, 2025
Q3
2025
Sep 30, 2024
($5.82M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($6.99M)
Aug 14, 2025
Q3
2024
Jun 30, 2024
($7.06M)
Nov 14, 2024
Q1
2025
Mar 31, 2024
($8.37M)
May 15, 2025
Q2
2024
Mar 31, 2024
($8.47M)
Aug 14, 2024
Q3
2024
Mar 31, 2024
($8.47M)
Nov 14, 2024
Q3
2024
Sep 30, 2023
($8.45M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($9.55M)
Aug 14, 2024
Q3
2024
Jun 30, 2023
($9.55M)
Nov 14, 2024
Q3
2024
Mar 31, 2023
($8.87M)
Nov 14, 2024
Q1
2024
Mar 31, 2023
($8.87M)
May 13, 2024
Q2
2024
Mar 31, 2023
($8.87M)
Aug 14, 2024
Q3
2023
Sep 30, 2022
($7.81M)
Nov 14, 2023
Q2
2022
Jun 30, 2022
($7.73M)
Aug 10, 2022
Q3
2023
Jun 30, 2022
($7.73M)
Nov 14, 2023
Q3
2023
Mar 31, 2022
($7.72M)
Nov 14, 2023
Q1
2023
Mar 31, 2022
($7.63M)
May 10, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($5.10M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($6.30M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($5.52M)
May 15, 2025
Q3
2025
Sep 30, 2024
($5.87M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($6.99M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($8.38M)
May 15, 2025
Q3
2024
Sep 30, 2023
($8.65M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($9.55M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($9.05M)
May 13, 2024
Q3
2023
Sep 30, 2022
($7.99M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($8.10M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($7.68M)
May 10, 2023
Q3
2022
Sep 30, 2021
($7.56M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($5.90M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($6.09M)
May 11, 2022
Q3
2021
Sep 30, 2020
($4.50M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($5.21M)
Aug 11, 2021
Q1
2021
Mar 31, 2020
($5.87M)
May 11, 2021
Q3
2020
Sep 30, 2019
($4.18M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($4.15M)
Aug 13, 2020